8-K
filed March 25, 2025, 7:59 PM ET
ticker PHGE
CIK 0001739174
earnings
confidence high
sentiment neutral
materiality 0.85
BiomX reports FY2024 results, $12M financing, Phase 2 DFO readout imminent
BiomX Inc.
- Phase 2 topline results for BX211 in diabetic foot osteomyelitis expected by end of March 2025.
- February 2025 financing raised ~$12M gross proceeds to support BX004 Phase 2b readout in Q1 2026.
- Cash and restricted cash $18.0M at Dec 31, 2024; plus $12M raised in Feb 2025; runway into Q1 2026.
- FY2024 net loss $17.7M (vs $26.2M); R&D expenses $24.7M; impairments on goodwill, IPR&D, and assets.
- Non-dilutive funding from DHA for BX211 totaled $36.8M to date; manufacturing delays for BX004 resolved.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001013762-25-001826
- form_type
- 8-K
- ticker
- PHGE
- cik
- 0001739174
- company_name
- BiomX Inc.
- filed_at
- 2025-03-25T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:04.675208+00:00
- generated_at
- 2026-05-24T05:53:35.136531+00:00
- sec_items
- ["2.02", "9.01"]
- event_type
- earnings
- sentiment
- neutral
- materiality_score
- 0.85
- calibrated_materiality_score
- 0.85
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001013762-25-001826
- json_url
- https://secwatch.observer/filing/0001013762-25-001826.json
- markdown_url
- https://secwatch.observer/filing/0001013762-25-001826.md
- text_url
- https://secwatch.observer/filing/0001013762-25-001826.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1739174/000101376225001826/0001013762-25-001826-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1739174/000101376225001826/ea0235496-8k_biomx.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
GMRS
GMR Solutions Q1 revenue $1.46B (+6.6% YoY), net income $106M (+180% YoY), guides FY26 rev $5.9-6.2B
GMR Solutions Inc.
June 1, 2026, 4:45 PM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
HPE
HPE Q2 FY26: record revenue $10.7B (+40%), raises FY26 guidance, introduces FY27 framework
Hewlett Packard Enterprise Co
June 1, 2026, 4:09 PM ET
earnings
Items 1.01, 2.02, 5.02, 7.01, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
CRDO
Credo Q4 revenue $437M (+157% YoY); guides Q1 $465-475M; CEO awarded 1.44M performance-based RSUs
Credo Technology Group Holding Ltd
June 1, 2026, 4:08 PM ET
earnings
Items 2.02, 5.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
RMCF
Rocky Mountain Chocolate Factory Q4 revenue down 24% to $6.8M; net loss per share widens to $0.38
Rocky Mountain Chocolate Factory, Inc.
June 1, 2026, 9:15 AM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
SAIC
SAIC Q1 adj EPS $3.23 beats $1.92; raises FY adj EBITDA and EPS guidance
Science Applications International Corp
June 1, 2026, 6:55 AM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
FNGR
FingerMotion FY2026 revenue down 32% to $24.1M; net loss widens to $7.0M
FingerMotion, Inc.
May 29, 2026, 5:12 PM ET
earnings
Items 2.02, 7.01, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
ELMT
Elmet Group Q1 revenue up 21% to $56M; adjusted EBITDA +106% to $9.2M; record backlog $113M
Elmet Group Co.
May 29, 2026, 8:05 AM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
GCO
Genesco reports Q1 sales beat, raises FY2027 EPS outlook; launches $40-50M cost program
GENESCO INC
May 29, 2026, 7:07 AM ET
earnings
Items 2.02, 9.01
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.